SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-016320
Filing Date
2021-03-30
Accepted
2021-03-30 07:30:29
Documents
5
Period of Report
2021-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fmtx-8k_20210330.htm 8-K 51223
2 EX-99.1 fmtx-ex991_6.htm EX-99.1 240849
3 EX-99.2 fmtx-ex992_34.htm EX-99.2 38817
4 GRAPHIC guqvf45otrfr000001.jpg GRAPHIC 14902
5 GRAPHIC gvlbtt2amckn000001.jpg GRAPHIC 46440
  Complete submission text file 0001564590-21-016320.txt   417143
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39333 | Film No.: 21783632
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences